AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Eurobio Scientific S.A.

€20.2 -$3.95 (-16.36%)
PAR · 15 Sep 2026 15:35 UTC
Previous Close
€20.4
Day Range
€19.45€20.6
Year Range
€19.2€25.7
Market Cap
203.38M
AVG Volume
1.51K
Trailing/Forward PE
42.98/17.88
PEG ratio
0.96
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Euronext ParisFR
Revenue (EUR)
025M50M75M100M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ALERS.PA Revenue (EUR) by quarter
PeriodRevenue (EUR)
25 Q487.5M
25 Q281.2M
24 Q481.63M
24 Q273.45M
23 Q471.27M
23 Q259.16M
22 Q468.85M
22 Q283.75M
21 Q488.98M
21 Q295.73M
Net Income (EUR)
010M20M30M40M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ALERS.PA Net Income (EUR) by quarter
PeriodNet Income (EUR)
25 Q42.54M
25 Q22.4M
24 Q41K
24 Q24M
23 Q42.64M
23 Q22.19M
22 Q45.71M
22 Q219.22M
21 Q427.48M
21 Q233.06M
Operating Income (EUR)
010M20M30M40M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ALERS.PA Operating Income (EUR) by quarter
PeriodOperating Income (EUR)
25 Q47.56M
25 Q25.8M
24 Q48.64M
24 Q26.83M
23 Q46.07M
23 Q24.07M
22 Q49.08M
22 Q221.95M
21 Q433.38M
21 Q238.6M
EBITDA (EUR)
020M40M60M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ALERS.PA EBITDA (EUR) by quarter
PeriodEBITDA (EUR)
25 Q49.08M
25 Q210.56M
24 Q48.19M
24 Q211.49M
23 Q413.82M
23 Q29.63M
22 Q413.98M
22 Q225.95M
21 Q435.59M
21 Q243.96M
Cash Flows (EUR)
010M20M30M40M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ALERS.PA Cash Flows (EUR) by quarter
PeriodCash Flows (EUR)
25 Q41.75M
25 Q22.81M
24 Q47.46M
24 Q25.99M
23 Q413.97M
23 Q27.39M
22 Q414.41M
22 Q224.61M
21 Q434.92M
21 Q228.7M
EPS (EUR)
012321 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ALERS.PA EPS (EUR) by quarter
PeriodEPS (EUR)
25 Q40.24
25 Q20.23
24 Q40
24 Q20.4
23 Q40.22
23 Q20.21
22 Q40.56
22 Q21.86
21 Q42.53
21 Q22.89
Expenses (EUR)
020M40M60MR&DSG&ACapex21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ALERS.PA Expenses (EUR) by quarter
PeriodExpenses (EUR)
25 Q440.74M
25 Q229.4M
24 Q429.42M
24 Q225.44M
23 Q424.53M
23 Q218.73M
22 Q420.07M
22 Q216.94M
21 Q414.84M
21 Q214.34M
Cash & Debt (EUR)
050M100M150MCashLong Term DebtShort Term Debt21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ALERS.PA Cash & Debt (EUR) by quarter
PeriodCash & Debt (EUR)
25 Q420.66M
25 Q226.86M
24 Q423.07M
24 Q286.59M
23 Q489.03M
23 Q270.75M
22 Q485.94M
22 Q2111.24M
21 Q4102.39M
21 Q273.01M
Debt ratios
-0.75-0.5-0.2500.250.521 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ALERS.PA Debt ratios by quarter
PeriodDebt ratios
25 Q4-0.12
25 Q2-0.15
24 Q40.25
24 Q20.14
23 Q40.18
23 Q20.42
22 Q40.23
22 Q2-0.56
21 Q4-0.51
21 Q2-0.4
Margins
0%20%40%60%21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ALERS.PA Margins by quarter
PeriodMargins
25 Q442.55%
25 Q247.04%
24 Q444.75%
24 Q245.4%
23 Q443.03%
23 Q240.02%
22 Q439.41%
22 Q245.26%
21 Q451.1%
21 Q254.29%
Return on Capital
0%10%20%30%21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ALERS.PA Return on Capital by quarter
PeriodReturn on Capital
25 Q41.38%
25 Q21.33%
24 Q40%
24 Q22.24%
23 Q41.52%
23 Q21.26%
22 Q43.32%
22 Q211.42%
21 Q417.19%
21 Q225.09%
Shares Outstanding
05M10M15M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ALERS.PA Shares Outstanding by quarter
PeriodShares Outstanding
25 Q410.42M
25 Q210.25M
24 Q410.25M
24 Q210.03M
23 Q49.16M
23 Q210.21M
22 Q410.22M
22 Q210.31M
21 Q410.85M
21 Q211.28M
Book Value Per Share (EUR)
0510152021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ALERS.PA Book Value Per Share (EUR) by quarter
PeriodBook Value Per Share (EUR)
25 Q417.65
25 Q217.65
24 Q417.45
24 Q217.83
23 Q419.04
23 Q217.09
22 Q416.86
22 Q216.33
21 Q414.74
21 Q211.69
Total Assets (EUR)
0100M200M300M400M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
ALERS.PA Total Assets (EUR) by quarter
PeriodTotal Assets (EUR)
25 Q4256.76M
25 Q2259.11M
24 Q4257.17M
24 Q2313.77M
23 Q4315.81M
23 Q2312.77M
22 Q4330.42M
22 Q2213.83M
21 Q4209.22M
21 Q2178.31M
PE Ratio
15202530med 26.67Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ALERS.PA PE Ratio by quarter
PeriodPE Ratio
Sep 2623.79
Sep 2623.68
Sep 2622.86
Aug 2623.33
Aug 2623.21
Aug 2624.26
Aug 2625.07
Jul 2623.33
Jul 2624.49
Jul 2624.14
Jul 2624.03
Jul 2625.07
Jun 2625.19
Jun 2625.89
Jun 2626.01
Jun 2626.47
May 2625.42
May 2625.89
May 2626.12
May 2626.01
Apr 2626.71
Apr 2627.87
Apr 2627.99
Apr 2627.17
Apr 2626.24
Mar 2625.1
Mar 2624.25
Mar 2625.61
Mar 2626.46
Feb 2626.63
Feb 2626.57
Feb 2627.25
Feb 2627.08
Jan 2627.08
Jan 2627.08
Jan 2626.97
Jan 2627.25
Jan 2627.37
Dec 2527.54
Dec 2527.59
Dec 2527.42
Dec 2527.82
Nov 2527.54
Nov 2528.16
Nov 2527.71
Nov 2527.76
Oct 2527.48
Oct 2527.88
Oct 2527.99
Oct 2528.16
Oct 2528.95
Sep 2529.35
Sep 2529.7
Sep 2529.52
Sep 2529.23
Aug 2529.58
Aug 2529.64
Aug 2529.52
Aug 2528.94
Aug 2529.46
Jul 2529.46
Jul 2529.52
Jul 2529.81
Jul 2529.29
Jun 2529.29
Jun 2529.46
Jun 2529.58
Jun 2529.29
May 2529
May 2529.58
May 2529.17
May 2529.35
May 2529.35
Apr 2528.26
Apr 2528.13
Apr 2527.96
Apr 2528.19
Mar 2517.57
Mar 2517.47
Mar 2517.47
Mar 2517.47
Feb 2517.47
Feb 2517.51
Feb 2517.54
Feb 2517.57
Jan 2518.26
Jan 2517.47
Jan 2517.47
Jan 2517.47
Jan 2517.44
Dec 2417.51
Dec 2417.44
Dec 2417.51
Dec 2417.68
Nov 2417.68
Nov 2417.75
Nov 2417.75
Nov 2417.75
Nov 2417.82
Oct 2417.82
Free Cash Flow Yield
5%7.5%10%12.5%15%17.5%med 13.24%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ALERS.PA Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 268.47%
Sep 268.51%
Sep 268.82%
Aug 268.64%
Aug 268.69%
Aug 268.31%
Aug 268.04%
Jul 268.64%
Jul 268.23%
Jul 268.35%
Jul 268.39%
Jul 268.04%
Jun 268%
Jun 267.79%
Jun 267.75%
Jun 267.61%
May 267.93%
May 267.79%
May 267.72%
May 267.75%
Apr 267.55%
Apr 267.23%
Apr 267.2%
Apr 267.42%
Apr 267.68%
Mar 2613.32%
Mar 2613.78%
Mar 2613.05%
Mar 2612.63%
Feb 2612.55%
Feb 2612.58%
Feb 2612.26%
Feb 2612.34%
Jan 2612.34%
Jan 2612.34%
Jan 2612.39%
Jan 2612.26%
Jan 2612.21%
Dec 2512.14%
Dec 2512.11%
Dec 2512.19%
Dec 2512.01%
Nov 2512.14%
Nov 2511.87%
Nov 2512.06%
Nov 2512.04%
Oct 2512.16%
Oct 2511.99%
Oct 2511.94%
Oct 2511.87%
Oct 2511.54%
Sep 2513.42%
Sep 2513.26%
Sep 2513.34%
Sep 2513.48%
Aug 2513.32%
Aug 2513.29%
Aug 2513.34%
Aug 2513.61%
Aug 2513.37%
Jul 2513.37%
Jul 2513.34%
Jul 2513.21%
Jul 2513.45%
Jun 2513.45%
Jun 2513.37%
Jun 2513.32%
Jun 2513.45%
May 2513.58%
May 2513.32%
May 2513.5%
May 2513.42%
May 2513.42%
Apr 2513.94%
Apr 2514%
Apr 2514.09%
Apr 2513.97%
Mar 2516.33%
Mar 2516.43%
Mar 2516.43%
Mar 2516.43%
Feb 2516.43%
Feb 2516.39%
Feb 2516.36%
Feb 2516.33%
Jan 2515.71%
Jan 2516.43%
Jan 2516.43%
Jan 2516.43%
Jan 2516.46%
Dec 2416.39%
Dec 2416.46%
Dec 2416.39%
Dec 2416.23%
Nov 2416.23%
Nov 2416.17%
Nov 2416.17%
Nov 2416.17%
Nov 2416.11%
Oct 2416.11%
Price to Sales
0.60.70.80.91med 0.84Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ALERS.PA Price to Sales by quarter
PeriodPrice to Sales
Sep 260.66
Sep 260.65
Sep 260.63
Aug 260.64
Aug 260.64
Aug 260.67
Aug 260.69
Jul 260.64
Jul 260.68
Jul 260.67
Jul 260.66
Jul 260.69
Jun 260.7
Jun 260.71
Jun 260.72
Jun 260.73
May 260.7
May 260.71
May 260.72
May 260.72
Apr 260.74
Apr 260.77
Apr 260.77
Apr 260.75
Apr 260.72
Mar 260.74
Mar 260.71
Mar 260.75
Mar 260.78
Feb 260.78
Feb 260.78
Feb 260.8
Feb 260.8
Jan 260.8
Jan 260.8
Jan 260.79
Jan 260.8
Jan 260.8
Dec 250.81
Dec 250.81
Dec 250.81
Dec 250.82
Nov 250.81
Nov 250.83
Nov 250.81
Nov 250.82
Oct 250.81
Oct 250.82
Oct 250.82
Oct 250.83
Oct 250.85
Sep 250.91
Sep 250.92
Sep 250.91
Sep 250.9
Aug 250.92
Aug 250.92
Aug 250.91
Aug 250.9
Aug 250.91
Jul 250.91
Jul 250.91
Jul 250.92
Jul 250.91
Jun 250.91
Jun 250.91
Jun 250.92
Jun 250.91
May 250.9
May 250.92
May 250.9
May 250.91
May 250.91
Apr 250.87
Apr 250.87
Apr 250.87
Apr 250.87
Mar 250.94
Mar 250.93
Mar 250.93
Mar 250.93
Feb 250.93
Feb 250.93
Feb 250.94
Feb 250.94
Jan 250.97
Jan 250.93
Jan 250.93
Jan 250.93
Jan 250.93
Dec 240.93
Dec 240.93
Dec 240.93
Dec 240.94
Nov 240.94
Nov 240.95
Nov 240.95
Nov 240.95
Nov 240.95
Oct 240.95
EV/EBITDA
4.555.566.5med 5.53Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ALERS.PA EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 265.29
Sep 265.26
Sep 265.08
Aug 265.18
Aug 265.16
Aug 265.4
Aug 265.58
Jul 265.18
Jul 265.45
Jul 265.37
Jul 265.34
Jul 265.58
Jun 265.61
Jun 265.77
Jun 265.79
Jun 265.9
May 265.66
May 265.77
May 265.82
May 265.79
Apr 265.95
Apr 266.22
Apr 266.25
Apr 266.06
Apr 265.85
Mar 265.01
Mar 264.83
Mar 265.11
Mar 265.28
Feb 265.32
Feb 265.31
Feb 265.45
Feb 265.41
Jan 265.41
Jan 265.41
Jan 265.39
Jan 265.45
Jan 265.47
Dec 255.51
Dec 255.52
Dec 255.48
Dec 255.56
Nov 255.51
Nov 255.63
Nov 255.54
Nov 255.55
Oct 255.49
Oct 255.58
Oct 255.6
Oct 255.63
Oct 255.8
Sep 256.27
Sep 256.34
Sep 256.3
Sep 256.24
Aug 256.31
Aug 256.33
Aug 256.3
Aug 256.18
Aug 256.29
Jul 256.29
Jul 256.3
Jul 256.36
Jul 256.26
Jun 256.26
Jun 256.29
Jun 256.31
Jun 256.26
May 256.2
May 256.31
May 256.23
May 256.27
May 256.27
Apr 256.04
Apr 256.02
Apr 255.98
Apr 256.03
Mar 255.37
Mar 255.33
Mar 255.33
Mar 255.33
Feb 255.33
Feb 255.34
Feb 255.35
Feb 255.37
Jan 255.57
Jan 255.33
Jan 255.33
Jan 255.33
Jan 255.32
Dec 245.34
Dec 245.32
Dec 245.34
Dec 245.4
Nov 245.4
Nov 245.42
Nov 245.42
Nov 245.42
Nov 245.44
Oct 245.44
Price/Operating Cashflow
5678med 6.56Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ALERS.PA Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 266.51
Sep 266.48
Sep 266.26
Aug 266.39
Aug 266.35
Aug 266.64
Aug 266.86
Jul 266.39
Jul 266.7
Jul 266.61
Jul 266.58
Jul 266.86
Jun 266.9
Jun 267.09
Jun 267.12
Jun 267.25
May 266.96
May 267.09
May 267.15
May 267.12
Apr 267.31
Apr 267.63
Apr 267.66
Apr 267.44
Apr 267.18
Mar 266.66
Mar 266.44
Mar 266.8
Mar 267.02
Feb 267.07
Feb 267.05
Feb 267.23
Feb 267.19
Jan 267.19
Jan 267.19
Jan 267.16
Jan 267.23
Jan 267.26
Dec 257.31
Dec 257.32
Dec 257.28
Dec 257.38
Nov 257.31
Nov 257.47
Nov 257.35
Nov 257.37
Oct 257.29
Oct 257.4
Oct 257.43
Oct 257.47
Oct 257.68
Sep 256.51
Sep 256.59
Sep 256.55
Sep 256.49
Aug 256.56
Aug 256.58
Aug 256.55
Aug 256.42
Aug 256.54
Jul 256.54
Jul 256.55
Jul 256.62
Jul 256.5
Jun 256.5
Jun 256.54
Jun 256.56
Jun 256.5
May 256.44
May 256.56
May 256.47
May 256.51
May 256.51
Apr 256.27
Apr 256.24
Apr 256.2
Apr 256.26
Mar 255.39
Mar 255.36
Mar 255.36
Mar 255.36
Feb 255.36
Feb 255.37
Feb 255.38
Feb 255.39
Jan 255.61
Jan 255.36
Jan 255.36
Jan 255.36
Jan 255.35
Dec 245.37
Dec 245.35
Dec 245.37
Dec 245.43
Nov 245.43
Nov 245.45
Nov 245.45
Nov 245.45
Nov 245.47
Oct 245.47
Price to Book
1.11.21.31.41.5med 1.39Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ALERS.PA Price to Book by quarter
PeriodPrice to Book
Sep 261.16
Sep 261.15
Sep 261.11
Aug 261.13
Aug 261.13
Aug 261.18
Aug 261.22
Jul 261.13
Jul 261.19
Jul 261.17
Jul 261.17
Jul 261.22
Jun 261.22
Jun 261.26
Jun 261.26
Jun 261.29
May 261.24
May 261.26
May 261.27
May 261.26
Apr 261.3
Apr 261.35
Apr 261.36
Apr 261.32
Apr 261.28
Mar 261.26
Mar 261.21
Mar 261.28
Mar 261.32
Feb 261.33
Feb 261.33
Feb 261.36
Feb 261.35
Jan 261.35
Jan 261.35
Jan 261.35
Jan 261.36
Jan 261.37
Dec 251.38
Dec 251.38
Dec 251.37
Dec 251.39
Nov 251.38
Nov 251.41
Nov 251.39
Nov 251.39
Oct 251.37
Oct 251.39
Oct 251.4
Oct 251.41
Oct 251.45
Sep 251.45
Sep 251.47
Sep 251.46
Sep 251.44
Aug 251.46
Aug 251.46
Aug 251.46
Aug 251.43
Aug 251.46
Jul 251.46
Jul 251.46
Jul 251.47
Jul 251.45
Jun 251.45
Jun 251.46
Jun 251.46
Jun 251.45
May 251.43
May 251.46
May 251.44
May 251.45
May 251.45
Apr 251.4
Apr 251.39
Apr 251.38
Apr 251.39
Mar 251.43
Mar 251.42
Mar 251.42
Mar 251.42
Feb 251.42
Feb 251.42
Feb 251.43
Feb 251.43
Jan 251.49
Jan 251.42
Jan 251.42
Jan 251.42
Jan 251.42
Dec 241.42
Dec 241.42
Dec 241.42
Dec 241.44
Nov 241.44
Nov 241.44
Nov 241.44
Nov 241.44
Nov 241.45
Oct 241.45
Eurobio Scientific S.A.
ALERS.PA
Stockpicker

Video analysis: ALERS.PA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.